MSP-4 can help induce the apoptosis of MG63 cells through the Fas/Fas ligand (FasL)- and mitochondria-mediated pathways, suggesting that it may be used as an innovative alternative treatment against human osteosarcoma [9]. The gene discussed is FASLG; the disease is osteosarcoma.